H. Larsson

发表

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine

B. Ahrén, H. Larsson, Bo Ahrén, 1998, Diabetologia.

Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.

J. Holst, B. Ahrén, H. Larsson, 1997, The Journal of clinical endocrinology and metabolism.

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.

B. Ahrén, H. Larsson, 2000, Diabetes care.

Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

B. Ahrén, H. Larsson, 2001, Diabetologia.

Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance

G. Berglund, B. Ahrén, F. Lindgärde, 1998, Diabetologia.

Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance

B. Ahrén, H. Larsson, Dr. B. Ahrén, 1996, Diabetologia.

Insulin sensitivity, insulin secretion, and glucose tolerance versus intima-media thickness in nondiabetic postmenopausal women.

G. Berglund, B. Ahrén, H. Larsson, 2003, The Journal of clinical endocrinology and metabolism.

Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.

B. Ahrén, H. Larsson, 1999, The Journal of clinical endocrinology and metabolism.

Evidence for leptin regulation of food intake in humans.

G. Berglund, B. Ahrén, S. Elmståhl, 1998, The Journal of clinical endocrinology and metabolism.

Androgen Activity as a Risk Factor for Impaired Glucose Tolerance in Postmenopausal Women

B. Ahrén, H. Larsson, 1996, Diabetes Care.

Smoking habits and circulating leptin in postmenopausal non‐obese women

B. Ahrén, H. Larsson, 1999, Diabetes, obesity & metabolism.

Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women.

B. Ahrén, H. Larsson, 1997, Metabolism: clinical and experimental.

Effects of Arginine on the Secretion of Insulin and Islet Amyloid Polypeptide in Humans

B. Ahrén, H. Larsson, 1995, Pancreas.

Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle‐aged women

G. Berglund, B. Ahrén, F. Lindgärde, 1995, Journal of internal medicine.

Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.

J. Holst, B. Ahrén, H. Larsson, 1997, European journal of endocrinology.

GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions

J. Holst, B. Ahrén, H. Larsson, 1997, Diabetes Care.

Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.

J. Holst, B. Ahrén, H. Larsson, 1997, Acta physiologica Scandinavica.

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.

Bo Ahrén, P. Jansson, M. Sandqvist, 2002, Diabetes care.

Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet

J. Holst, B. Ahrén, H. Larsson, 1996, Diabetes Care.

Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study

G. Berglund, B. Ahrén, F. Lindgärde, 2000, Diabetologia.

Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.

B. Ahrén, H. Larsson, B. Ahrén, 1999, The Journal of clinical endocrinology and metabolism.

Characterization of Impaired Glucose Tolerance - Insulin Sensitivity, Islet Function and Metabolic Risk Factors

H. Larsson, 1999 .

Peptide YY does not inhibit glucose-stimulated insulin secretion in humans.

B. Ahrén, H. Larsson, 1996, European journal of endocrinology.

Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women

B. Ahrén, H. Larsson, H. Larsson, 2000, Diabetologia.

Regulation of circulating leptin in humans

T. Olsson, B. Ahrén, H. Larsson, 1997, Endocrine.

Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.

G. Berglund, B. Ahrén, B Ahrén, 1995, The Journal of clinical endocrinology and metabolism.

Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women.

B. Ahrén, H. Larsson, Bo Ahrén, 1996, The Journal of clinical endocrinology and metabolism.

Plasma Leptin Levels Correlate to Islet Function Independently of Body Fat in Postmenopausal Women

B. Ahrén, S. Elmståhl, H. Larsson, 1996, Diabetes.

Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.

B. Ahrén, H. Larsson, 2002, Diabetes.

Section 5: Methodology for Quantifying Insulin Release in Man Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal

H. Larsson, 2002 .

Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity

B. Ahrén, H. Larsson, 1999, Diabetologia.

Habitual dietary intake versus glucose tolerance, insulin sensitivity and insulin secretion in postmenopausal women

G. Berglund, B. Ahrén, S. Elmståhl, 1999, Journal of internal medicine.

Plasma neuropeptide Y in impaired glucose tolerance

B. Ahrén, H. Larsson, 1996, Acta Diabetologica.

Islet dysfunction in obese women with impaired glucose tolerance.

B. Ahrén, H. Larsson, 1996, Metabolism: clinical and experimental.

Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance.

B. Kiens, J. Daugaard, B. Ahrén, 1999, Diabetes care.